Orbem

Orbem is a German-based startup revolutionizing imaging technology by integrating rapid magnetic resonance imaging with advanced deep learning. Founded in 2019 as a spin-off from the Technical University of Munich, Orbem's mission is to develop fast, accurate, and accessible imaging solutions that address some of the world's toughest challenges. The company's flagship product, the Genus, combines MRI with AI for contactless object classification and analytics. Orbem's focus on leveraging deep tech solutions to sustainably feed the world, accelerate the transition to a green economy, and transform disease detection underscores its commitment to making a difference. The company's dedication to innovation is reflected in its diverse and multidisciplinary team, which is continuously exploring new frontiers to build a sustainable and healthy future. In October 2023, Orbem secured a €30.00M Series A investment from prominent investors including The Venture Collective (TVC), 83North, Possible Ventures, La Famiglia, and individual investors such as Roman Schumacher, Dr.-Ing. Michael Berlin, Michael Wax, Hanno Renner, Jonas Rieke, and Rüdiger Schmidt. This funding will undoubtedly fuel Orbem's efforts to further develop and commercialize its AI-powered imaging technology. Orbem's innovative approach to AI, information technology, and autonomous and sensor tech places them at the forefront of imaging solutions, offering compelling opportunities for potential investors and collaborators seeking to impact the future of imaging technology on a global scale. Discover more about Orbem and its transformative Genus product at orbem.ai, and be part of shaping the future of AI-powered imaging with this visionary company.